Table 1—

MTAs against HB virus (anti-HBs mIU/ml) of children in groups A and B 4–5 weeks after the administration of the first, second, and third dose of HB vaccine

nFirst doseSecond doseThird dose
Group A (Engerix-B)100 (0–3.19)15.44 (0–1,000)157.5 (4.54–1,630)
Group B (GenHevac-B)108 (0–150)128.5 (0–1,000)1,000 (170–2,796)
  • Data are median (range) unless otherwise indicated. For first and second dose, P = NS; for third dose, P = 0.014.